Filing Details

Accession Number:
0001267602-18-000024
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-19 16:39:39
Reporting Period:
2018-01-18
Accepted Time:
2018-01-19 16:39:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374256 Jr S Richard Eiswirth 6120 Windward Parkway, Suite 290
Alpharetta GA 30005
President And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-18 6,601 $1.22 84,779 No 4 S Direct
Common Stock Disposition 2018-01-19 6,809 $1.18 77,970 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of Restricted Stock Units as reflected in this Form 4. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.